11:22 AM EST - Concordia International Corp. : Announced today its intention to change its name as part of a global rebrand in support of its strategy and vision. Subject to the customary approvals, including stock exchange and shareholder approvals, the Company intends to rebrand as ADVANZ PHARMA during the fourth quarter of 2018. Concordia International Corp.
shares T.CXR are trading up $0.69 at $27.06.
